US89377M1099
US89377M1099
TransMedics Group, Inc.
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 75/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.9x as much as the broader market.
Beta (Market Relation)
1.93x
Above averageVolatility (5Y p.a.)
71.4% p.a.
5-Year HorizonMax Drawdown (5Y)
-67.8%
5-Year HorizonSharpe Ratio
0.30
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -33.1% |
| 3 Years | 68.9% | -67.8% | 0.23 | +18% |
| 5 Years | 71.4% | -67.8% | 0.3 | +23.6% |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.93 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (71.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -67.8% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
10 ISS Score: 10 / 10
Board Risk
3 ISS Score: 3 / 10
Short Ratio
11.43